Luis Calderón – General Manager, Alexion Mexico
Mexico is improving its regulatory framework for orphan drugs. The general manager of Alexion Mexico explains how the company is working with the authorities to ensure adequate regulation is put…
Alexion is a global biopharmaceutical company that combines groundbreaking science with a steadfast commitment to meeting the needs of patients living with severe, life-threatening and often ultra-rare diseases. Alexion scientists are among the first in the world to unlock the therapeutic potential of inhibiting terminal complement, a group of proteins that play an important role in the body’s immune response and can destroy healthy tissue in certain patients. Alexion discovered and developed Soliris® (eculizumab), a first-in-class terminal complement inhibitor, approved in the United States, Canada, European Union, Australia, and Japan as a treatment for patients with paroxysmal nocturnal hemoglobinuria (PNH). Alexion is working urgently to investigate Soliris and additional biopharmaceuticals as treatments for patients with other rare and severe diseases, including cancer.
Contact details
Alexion
Paseo de los Tamarindos 90
Torre 1 Piso 6 Oficina A
Col. Bosque de la Lomas, Del. Cuajimalpa,
C.P. 05120, México DF
MEXICO
Tel: +52 (55) 5047 1500
Website: http://alxn.com/
Mexico is improving its regulatory framework for orphan drugs. The general manager of Alexion Mexico explains how the company is working with the authorities to ensure adequate regulation is put…
“As Mexicans we must be prepared for a new stage of our country’s development”. These were the inspiring words of newly elected Mexican President Peña Nieto, who has promised…
A Regulatory Overview of the Mexican Healthcare market by ALEJANDRO LUNA FANDIÑO, Partner Olivares & Cia. Olivares & Cia T +52 55 5322 3080 F +52 55 5322 3001 E…
Beyond the bright lights of Mexico City’s Santa Fe and Polanco districts, roughly half of Mexicans lack access to quality healthcare or medicines. This presents a challenge for pharma companies…
In the late 1990s, Rodrigo Herrera Aspra wanted to commercialize a new anti-acne formulation, and was advised by a friend who was involved in the pharmaceutical industry to hire a…
As in many emerging countries, it is taking a while for Mexican legislation to catch up with the latest technologies. Alejandra Mendoza, general manager of Genzyme Mexico, says that regulation…
3M is a global company with a very diverse range of activities & business. Can you present us the portfolio of activities of 3M Mexico healthcare division? As a global…
Bioethics encompasses a wide range of disciplines in health care, health science and health policy. Ethical standards apply at all levels inside the company and outside with the stakeholders. Could…
St Jude Medical has over 16,000 employees worldwide, its products are sold in over 100 countries, and specializes in cardiac and neurological medical devices and services. The company established a…
Can you give us a historical overview of the main milestones and achievements of Ottobock since it settled in Mexico in 1995? Ottobock was founded in 1919 by Doctor Ottobock…
Can you give us a historical overview of the company and tell us about the vision behind its creation? Vitalmex is a very humanistic company that puts the patient at…
IMSS is a central pillar in the Mexican healthcare system, covering all Mexicans working for the declared formal private sector. How do you assess the quality of the healthcare that…
PwC has been the advocate of convergence in the industry for a very long time, what does that mean and what are the implications for the Mexican healthcare system? At…
See our Cookie Privacy Policy Here
